Low rates of mutation in clinical grade human pluripotent stem cells under different culture conditions

The occurrence of repetitive genomic changes that provide a selective growth advantage in pluripotent stem cells is of concern for their clinical application. However, the effect of different culture conditions on the underlying mutation rate is unknown. Here we show that the mutation rate in two hu...

Full description

Saved in:
Bibliographic Details
Published inNature communications Vol. 11; no. 1; pp. 1528 - 14
Main Authors Thompson, Oliver, von Meyenn, Ferdinand, Hewitt, Zoe, Alexander, John, Wood, Andrew, Weightman, Richard, Gregory, Sian, Krueger, Felix, Andrews, Simon, Barbaric, Ivana, Gokhale, Paul J., Moore, Harry D., Reik, Wolf, Milo, Marta, Nik-Zainal, Serena, Yusa, Kosuke, Andrews, Peter W.
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 23.03.2020
Nature Publishing Group
Nature Portfolio
Subjects
Online AccessGet full text
ISSN2041-1723
2041-1723
DOI10.1038/s41467-020-15271-3

Cover

Loading…
Abstract The occurrence of repetitive genomic changes that provide a selective growth advantage in pluripotent stem cells is of concern for their clinical application. However, the effect of different culture conditions on the underlying mutation rate is unknown. Here we show that the mutation rate in two human embryonic stem cell lines derived and banked for clinical application is low and not substantially affected by culture with Rho Kinase inhibitor, commonly used in their routine maintenance. However, the mutation rate is reduced by >50% in cells cultured under 5% oxygen, when we also found alterations in imprint methylation and reversible DNA hypomethylation. Mutations are evenly distributed across the chromosomes, except for a slight increase on the X-chromosome, and an elevation in intergenic regions suggesting that chromatin structure may affect mutation rate. Overall the results suggest that pluripotent stem cells are not subject to unusually high rates of genetic or epigenetic alterations. Mutations in human pluripotent stem cells (PSC) and whether any form during culture prior to use in a human clinical context are a concern. Here, the authors use hPSCs derived to cGMP standards and show they have low mutation rates after culture, noting this decreases on culturing in low (5%) oxygen conditions.
AbstractList The occurrence of repetitive genomic changes that provide a selective growth advantage in pluripotent stem cells is of concern for their clinical application. However, the effect of different culture conditions on the underlying mutation rate is unknown. Here we show that the mutation rate in two human embryonic stem cell lines derived and banked for clinical application is low and not substantially affected by culture with Rho Kinase inhibitor, commonly used in their routine maintenance. However, the mutation rate is reduced by >50% in cells cultured under 5% oxygen, when we also found alterations in imprint methylation and reversible DNA hypomethylation. Mutations are evenly distributed across the chromosomes, except for a slight increase on the X-chromosome, and an elevation in intergenic regions suggesting that chromatin structure may affect mutation rate. Overall the results suggest that pluripotent stem cells are not subject to unusually high rates of genetic or epigenetic alterations.
The occurrence of repetitive genomic changes that provide a selective growth advantage in pluripotent stem cells is of concern for their clinical application. However, the effect of different culture conditions on the underlying mutation rate is unknown. Here we show that the mutation rate in two human embryonic stem cell lines derived and banked for clinical application is low and not substantially affected by culture with Rho Kinase inhibitor, commonly used in their routine maintenance. However, the mutation rate is reduced by >50% in cells cultured under 5% oxygen, when we also found alterations in imprint methylation and reversible DNA hypomethylation. Mutations are evenly distributed across the chromosomes, except for a slight increase on the X-chromosome, and an elevation in intergenic regions suggesting that chromatin structure may affect mutation rate. Overall the results suggest that pluripotent stem cells are not subject to unusually high rates of genetic or epigenetic alterations.The occurrence of repetitive genomic changes that provide a selective growth advantage in pluripotent stem cells is of concern for their clinical application. However, the effect of different culture conditions on the underlying mutation rate is unknown. Here we show that the mutation rate in two human embryonic stem cell lines derived and banked for clinical application is low and not substantially affected by culture with Rho Kinase inhibitor, commonly used in their routine maintenance. However, the mutation rate is reduced by >50% in cells cultured under 5% oxygen, when we also found alterations in imprint methylation and reversible DNA hypomethylation. Mutations are evenly distributed across the chromosomes, except for a slight increase on the X-chromosome, and an elevation in intergenic regions suggesting that chromatin structure may affect mutation rate. Overall the results suggest that pluripotent stem cells are not subject to unusually high rates of genetic or epigenetic alterations.
The occurrence of repetitive genomic changes that provide a selective growth advantage in pluripotent stem cells is of concern for their clinical application. However, the effect of different culture conditions on the underlying mutation rate is unknown. Here we show that the mutation rate in two human embryonic stem cell lines derived and banked for clinical application is low and not substantially affected by culture with Rho Kinase inhibitor, commonly used in their routine maintenance. However, the mutation rate is reduced by >50% in cells cultured under 5% oxygen, when we also found alterations in imprint methylation and reversible DNA hypomethylation. Mutations are evenly distributed across the chromosomes, except for a slight increase on the X-chromosome, and an elevation in intergenic regions suggesting that chromatin structure may affect mutation rate. Overall the results suggest that pluripotent stem cells are not subject to unusually high rates of genetic or epigenetic alterations. Mutations in human pluripotent stem cells (PSC) and whether any form during culture prior to use in a human clinical context are a concern. Here, the authors use hPSCs derived to cGMP standards and show they have low mutation rates after culture, noting this decreases on culturing in low (5%) oxygen conditions.
The occurrence of repetitive genomic changes that provide a selective growth advantage in pluripotent stem cells is of concern for their clinical application. However, the effect of different culture conditions on the underlying mutation rate is unknown. Here we show that the mutation rate in two human embryonic stem cell lines derived and banked for clinical application is low and not substantially affected by culture with Rho Kinase inhibitor, commonly used in their routine maintenance. However, the mutation rate is reduced by >50% in cells cultured under 5% oxygen, when we also found alterations in imprint methylation and reversible DNA hypomethylation. Mutations are evenly distributed across the chromosomes, except for a slight increase on the X-chromosome, and an elevation in intergenic regions suggesting that chromatin structure may affect mutation rate. Overall the results suggest that pluripotent stem cells are not subject to unusually high rates of genetic or epigenetic alterations.Mutations in human pluripotent stem cells (PSC) and whether any form during culture prior to use in a human clinical context are a concern. Here, the authors use hPSCs derived to cGMP standards and show they have low mutation rates after culture, noting this decreases on culturing in low (5%) oxygen conditions.
Mutations in human pluripotent stem cells (PSC) and whether any form during culture prior to use in a human clinical context are a concern. Here, the authors use hPSCs derived to cGMP standards and show they have low mutation rates after culture, noting this decreases on culturing in low (5%) oxygen conditions.
ArticleNumber 1528
Author Yusa, Kosuke
Andrews, Simon
Andrews, Peter W.
Reik, Wolf
Thompson, Oliver
Moore, Harry D.
Krueger, Felix
Alexander, John
Wood, Andrew
von Meyenn, Ferdinand
Barbaric, Ivana
Hewitt, Zoe
Milo, Marta
Gregory, Sian
Nik-Zainal, Serena
Weightman, Richard
Gokhale, Paul J.
Author_xml – sequence: 1
  givenname: Oliver
  surname: Thompson
  fullname: Thompson, Oliver
  organization: The Centre for Stem Cell Biology, Department of Biomedical Science, University of Sheffield, Western Bank
– sequence: 2
  givenname: Ferdinand
  orcidid: 0000-0001-9920-3075
  surname: von Meyenn
  fullname: von Meyenn, Ferdinand
  organization: Epigenetics Programme, Babraham Institute, Department of Medical & Molecular Genetics, King’s College London, Institute of Food, Nutrition and Health, ETH Zurich
– sequence: 3
  givenname: Zoe
  orcidid: 0000-0001-7519-7029
  surname: Hewitt
  fullname: Hewitt, Zoe
  organization: The Centre for Stem Cell Biology, Department of Biomedical Science, University of Sheffield, Western Bank
– sequence: 4
  givenname: John
  orcidid: 0000-0003-3973-6501
  surname: Alexander
  fullname: Alexander, John
  organization: The Centre for Stem Cell Biology, Department of Biomedical Science, University of Sheffield, Western Bank, Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research
– sequence: 5
  givenname: Andrew
  orcidid: 0000-0002-5973-2092
  surname: Wood
  fullname: Wood, Andrew
  organization: The Centre for Stem Cell Biology, Department of Biomedical Science, University of Sheffield, Western Bank
– sequence: 6
  givenname: Richard
  orcidid: 0000-0002-2593-8631
  surname: Weightman
  fullname: Weightman, Richard
  organization: The Centre for Stem Cell Biology, Department of Biomedical Science, University of Sheffield, Western Bank
– sequence: 7
  givenname: Sian
  orcidid: 0000-0002-3014-2603
  surname: Gregory
  fullname: Gregory, Sian
  organization: The Centre for Stem Cell Biology, Department of Biomedical Science, University of Sheffield, Western Bank
– sequence: 8
  givenname: Felix
  orcidid: 0000-0002-5513-3324
  surname: Krueger
  fullname: Krueger, Felix
  organization: Bioinformatics Group, Babraham Institute
– sequence: 9
  givenname: Simon
  surname: Andrews
  fullname: Andrews, Simon
  organization: Bioinformatics Group, Babraham Institute
– sequence: 10
  givenname: Ivana
  surname: Barbaric
  fullname: Barbaric, Ivana
  organization: The Centre for Stem Cell Biology, Department of Biomedical Science, University of Sheffield, Western Bank
– sequence: 11
  givenname: Paul J.
  orcidid: 0000-0001-7225-4403
  surname: Gokhale
  fullname: Gokhale, Paul J.
  organization: The Centre for Stem Cell Biology, Department of Biomedical Science, University of Sheffield, Western Bank
– sequence: 12
  givenname: Harry D.
  surname: Moore
  fullname: Moore, Harry D.
  organization: The Centre for Stem Cell Biology, Department of Biomedical Science, University of Sheffield, Western Bank
– sequence: 13
  givenname: Wolf
  surname: Reik
  fullname: Reik, Wolf
  organization: Epigenetics Programme, Babraham Institute, Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton
– sequence: 14
  givenname: Marta
  orcidid: 0000-0002-6996-6431
  surname: Milo
  fullname: Milo, Marta
  organization: The Centre for Stem Cell Biology, Department of Biomedical Science, University of Sheffield, Western Bank
– sequence: 15
  givenname: Serena
  orcidid: 0000-0001-5054-1727
  surname: Nik-Zainal
  fullname: Nik-Zainal, Serena
  organization: Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Academic Laboratory of Medical Genetics, Cambridge University Hospitals NHS Foundation Trust, Box 238, Lv6 Addenbrooke’ Treatment Centre, Cambridge Biomedical Research Campus, MRC Cancer Unit, University of Cambridge, Hutchinson/MRC Research Centre, Box 1297, Cambridge Biomedical Campus
– sequence: 16
  givenname: Kosuke
  orcidid: 0000-0002-3442-021X
  surname: Yusa
  fullname: Yusa, Kosuke
  email: k.yusa@infront.kyoto-u.ac.jp
  organization: Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Institute for Frontier Life and Medical Sciences, Kyoto University
– sequence: 17
  givenname: Peter W.
  orcidid: 0000-0001-7215-4410
  surname: Andrews
  fullname: Andrews, Peter W.
  email: p.w.andrews@sheffield.ac.uk
  organization: The Centre for Stem Cell Biology, Department of Biomedical Science, University of Sheffield, Western Bank
BackLink https://www.ncbi.nlm.nih.gov/pubmed/32251294$$D View this record in MEDLINE/PubMed
BookMark eNp9Uk1vFSEUnZgaW2v_gAtD4sbNKJ_DsDExja1NXuJG1wQYmPLCwBNmbPz3Mp1W2y56NxDuOSeHe8_r5iimaJvmLYIfEST9p0IR7XgLMWwRwxy15EVzgiFFLeKYHD24HzdnpexhLSJQT-mr5phgzBAW9KQZd-kGZDXbApID0zKr2acIfAQm-OiNCmDMarDgeplUBIewZH9Is40zKLOdgLEhFLDEwWYweOdsXltmCfOSLTApDn4VLG-al06FYs_uztPm58XXH-ff2t33y6vzL7vWMArnVg-aGeV0NS-EoNgJqxUXDBIGRedc1w1EC2XQIJjodUe4GgxnEDmotcWInDZXm-6Q1F4esp9U_iOT8vL2IeVRqjx7E6zsHGMWQs4rm0JENFFcC44o6XRfq2p93rQOi57sYOrPsgqPRB93or-WY_otOeyF6HgV-HAnkNOvxZZZTr6sE1PRpqVITHqOGWH96vv9E-g-LTnWUa0oDAlFsKuodw8d_bNyv88K6DeAyamUbJ00fltpNeiDRFCu6ZFbemRNj7xNjySVip9Q79WfJZGNVCo4jjb_t_0M6y-1Dtcv
CitedBy_id crossref_primary_10_1016_j_xpro_2025_103630
crossref_primary_10_1134_S0006297924050031
crossref_primary_10_1002_adbi_202400538
crossref_primary_10_3390_biomedicines10051204
crossref_primary_10_1016_j_stem_2021_07_012
crossref_primary_10_1039_D4FO03078H
crossref_primary_10_1038_s41419_022_05413_4
crossref_primary_10_1089_scd_2021_0013
crossref_primary_10_1016_j_jcyt_2022_08_001
crossref_primary_10_3389_fphys_2023_1331974
crossref_primary_10_3390_cells13161395
crossref_primary_10_1186_s12864_024_10329_8
crossref_primary_10_1038_s12276_024_01334_8
crossref_primary_10_3390_genes14061291
crossref_primary_10_1016_j_psj_2023_103280
crossref_primary_10_1111_cpr_12892
crossref_primary_10_1038_s41598_024_77972_9
crossref_primary_10_1016_j_stemcr_2024_08_004
crossref_primary_10_31857_S0320972524050036
crossref_primary_10_3390_ijms241310871
crossref_primary_10_1186_s12864_022_08479_8
crossref_primary_10_1016_j_stem_2022_11_006
crossref_primary_10_2217_rme_2021_0013
crossref_primary_10_1038_s41588_022_01147_3
crossref_primary_10_3390_ani13010127
crossref_primary_10_1016_j_cbpb_2021_110570
crossref_primary_10_1016_j_stemcr_2023_05_004
crossref_primary_10_1093_gbe_evab148
crossref_primary_10_1089_crispr_2022_0050
crossref_primary_10_1093_nar_gkad775
crossref_primary_10_1007_s12033_024_01259_7
crossref_primary_10_3390_cells10113246
crossref_primary_10_1016_j_cbd_2024_101336
crossref_primary_10_1016_j_aquaculture_2024_741173
crossref_primary_10_1007_s11427_023_2354_6
crossref_primary_10_3390_plants12030538
crossref_primary_10_1016_j_intimp_2024_113876
crossref_primary_10_1038_s41423_024_01213_2
crossref_primary_10_1016_j_biomaterials_2023_122033
crossref_primary_10_1177_10732748241270564
crossref_primary_10_1016_j_stemcr_2023_01_007
crossref_primary_10_1093_nar_gkab914
crossref_primary_10_1016_j_regen_2024_100078
crossref_primary_10_1016_j_isci_2022_103736
crossref_primary_10_1089_scd_2021_0079
crossref_primary_10_1016_j_ijbiomac_2024_135067
crossref_primary_10_1016_j_plaphy_2025_109828
crossref_primary_10_1002_2211_5463_13581
crossref_primary_10_1615_CritRevOncog_2022042332
crossref_primary_10_1038_s41580_020_00292_z
crossref_primary_10_3390_ijms231810924
crossref_primary_10_1155_2021_5575185
crossref_primary_10_1073_pnas_2305187120
crossref_primary_10_1016_j_stemcr_2020_04_004
crossref_primary_10_1038_s12276_022_00907_9
crossref_primary_10_5483_BMBRep_2021_54_10_094
crossref_primary_10_1016_j_stemcr_2022_01_019
crossref_primary_10_1016_j_arr_2021_101316
crossref_primary_10_1016_j_scienta_2024_113521
crossref_primary_10_34133_bmr_0093
crossref_primary_10_1007_s11626_024_00865_8
crossref_primary_10_1038_s41598_021_95224_y
crossref_primary_10_3390_ijms23020855
crossref_primary_10_1016_j_xpro_2020_100213
crossref_primary_10_1016_j_postharvbio_2024_112849
crossref_primary_10_1007_s11103_024_01448_7
crossref_primary_10_2147_JIR_S495512
crossref_primary_10_1080_14712598_2023_2225701
crossref_primary_10_3389_fnmol_2023_1173433
crossref_primary_10_3390_cells11131984
crossref_primary_10_1016_j_aqrep_2024_102494
crossref_primary_10_1038_s41598_021_03658_1
crossref_primary_10_3390_antiox13121545
crossref_primary_10_1016_j_stemcr_2023_11_013
Cites_doi 10.1016/j.stem.2013.06.004
10.1371/journal.pgen.1005932
10.1016/j.stemcr.2013.10.005
10.1038/ncomms15183
10.1016/j.cell.2019.03.001
10.1089/clo.2006.8.16
10.1016/j.cell.2012.04.024
10.1038/nbt.2051
10.1016/j.stemcr.2014.05.006
10.1089/scd.2013.0504
10.1038/nature08658
10.1038/nbt.1510
10.1093/molehr/gat077
10.1038/nbt1285
10.1016/j.scr.2009.09.001
10.1371/journal.pone.0078847
10.1038/nature23286
10.1038/nrm2354
10.1016/j.stemcr.2016.10.003
10.1016/j.stem.2012.02.014
10.1016/j.devcel.2016.09.015
10.1016/j.celrep.2018.06.091
10.1371/journal.pone.0118307
10.1016/j.stem.2016.01.019
10.1038/s41467-018-04052-8
10.1242/dev.146811
10.1002/stem.1117
10.1093/hmg/ddm074
10.1093/nar/gky1015
10.1038/nature22312
10.1073/pnas.062527199
10.1038/nrm.2016.88
10.1093/hmg/ddi345
10.1093/bioinformatics/btr167
10.1093/hmg/ddm245
10.1016/j.stemcr.2016.01.015
10.1016/j.stemcr.2017.05.029
10.1038/ng.3991
10.1016/j.stemcr.2016.02.005
10.1007/s12015-016-9662-8
10.1038/nbt.1509
10.1101/gr.6609207
10.1056/NEJMc1706274
10.1038/embor.2012.165
10.1038/nbt922
10.1038/nature12477
10.1038/ncomms10536
10.1016/j.cell.2019.02.012
10.1038/nbt1310
10.1093/bioinformatics/btv408
10.1101/430165
10.1002/stem.451
ContentType Journal Article
Copyright The Author(s) 2020
This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: The Author(s) 2020
– notice: This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID C6C
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7QL
7QP
7QR
7SN
7SS
7ST
7T5
7T7
7TM
7TO
7X7
7XB
88E
8AO
8FD
8FE
8FG
8FH
8FI
8FJ
8FK
ABUWG
AEUYN
AFKRA
ARAPS
AZQEC
BBNVY
BENPR
BGLVJ
BHPHI
C1K
CCPQU
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
H94
HCIFZ
K9.
LK8
M0S
M1P
M7P
P5Z
P62
P64
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
RC3
SOI
7X8
5PM
DOA
DOI 10.1038/s41467-020-15271-3
DatabaseName Springer Nature OA Free Journals
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Bacteriology Abstracts (Microbiology B)
Calcium & Calcified Tissue Abstracts
Chemoreception Abstracts
Ecology Abstracts
Entomology Abstracts (Full archive)
Environment Abstracts
Immunology Abstracts
Industrial and Applied Microbiology Abstracts (Microbiology A)
Nucleic Acids Abstracts
Oncogenes and Growth Factors Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Technology Research Database
ProQuest SciTech Collection
ProQuest Technology Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest One Sustainability
ProQuest Central UK/Ireland
Advanced Technologies & Aerospace Collection
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Technology Collection
Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest One Community College
ProQuest Central Korea
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
AIDS and Cancer Research Abstracts
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
Health & Medical Collection (Alumni)
Medical Database
Biological Science Database
ProQuest advanced technologies & aerospace journals
ProQuest Advanced Technologies & Aerospace Collection
Biotechnology and BioEngineering Abstracts
ProQuest Central Premium
ProQuest One Academic
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
Genetics Abstracts
Environment Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest Central Student
Oncogenes and Growth Factors Abstracts
ProQuest Advanced Technologies & Aerospace Collection
ProQuest Central Essentials
Nucleic Acids Abstracts
SciTech Premium Collection
ProQuest Central China
Environmental Sciences and Pollution Management
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
Health Research Premium Collection
Natural Science Collection
Health & Medical Research Collection
Biological Science Collection
Chemoreception Abstracts
Industrial and Applied Microbiology Abstracts (Microbiology A)
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Advanced Technologies & Aerospace Collection
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
ProQuest Technology Collection
Health Research Premium Collection (Alumni)
Biological Science Database
Ecology Abstracts
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
Entomology Abstracts
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
Engineering Research Database
ProQuest One Academic
Calcium & Calcified Tissue Abstracts
ProQuest One Academic (New)
Technology Collection
Technology Research Database
ProQuest One Academic Middle East (New)
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central
ProQuest Health & Medical Research Collection
Genetics Abstracts
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Bacteriology Abstracts (Microbiology B)
AIDS and Cancer Research Abstracts
ProQuest SciTech Collection
Advanced Technologies & Aerospace Database
ProQuest Medical Library
Immunology Abstracts
Environment Abstracts
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic

Publicly Available Content Database


CrossRef
Database_xml – sequence: 1
  dbid: C6C
  name: Springer Nature OA Free Journals
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 3
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 4
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 5
  dbid: 8FG
  name: ProQuest Technology Collection
  url: https://search.proquest.com/technologycollection1
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 2041-1723
EndPage 14
ExternalDocumentID oai_doaj_org_article_6f55e007701f4013b3a7b971436b8888
PMC7089967
32251294
10_1038_s41467_020_15271_3
Genre Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: Cancer Research UK
  grantid: 22932
– fundername: Medical Research Council
  grantid: MR/L012537/1
– fundername: Cancer Research UK
  grantid: 23433
– fundername: Cancer Research UK
  grantid: 23916
– fundername: Cancer Research UK
  grantid: 27815
– fundername: Wellcome Trust
  grantid: 206194
– fundername: Wellcome Trust
  grantid: WT206194
– fundername: Cancer Research UK
  grantid: A23916
GroupedDBID ---
0R~
39C
3V.
53G
5VS
70F
7X7
88E
8AO
8FE
8FG
8FH
8FI
8FJ
AAHBH
AAJSJ
ABUWG
ACGFO
ACGFS
ACIWK
ACMJI
ACPRK
ACSMW
ADBBV
ADFRT
ADMLS
ADRAZ
AENEX
AEUYN
AFKRA
AFRAH
AHMBA
AJTQC
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMTXH
AOIJS
ARAPS
ASPBG
AVWKF
AZFZN
BBNVY
BCNDV
BENPR
BGLVJ
BHPHI
BPHCQ
BVXVI
C6C
CCPQU
DIK
EBLON
EBS
EE.
EMOBN
F5P
FEDTE
FYUFA
GROUPED_DOAJ
HCIFZ
HMCUK
HVGLF
HYE
HZ~
KQ8
LK8
M1P
M48
M7P
M~E
NAO
O9-
OK1
P2P
P62
PIMPY
PQQKQ
PROAC
PSQYO
RNS
RNT
RNTTT
RPM
SNYQT
SV3
TSG
UKHRP
AASML
AAYXX
CITATION
PHGZM
PHGZT
CGR
CUY
CVF
ECM
EIF
NPM
PJZUB
PPXIY
PQGLB
7QL
7QP
7QR
7SN
7SS
7ST
7T5
7T7
7TM
7TO
7XB
8FD
8FK
AARCD
AZQEC
C1K
DWQXO
FR3
GNUQQ
H94
K9.
P64
PKEHL
PQEST
PQUKI
PRINS
RC3
SOI
7X8
PUEGO
5PM
ID FETCH-LOGICAL-c540t-bdb5cafb20499942f9eba795035096ff66d3b9ac1d9598b637adc7501f0bbe213
IEDL.DBID BENPR
ISSN 2041-1723
IngestDate Wed Aug 27 01:27:17 EDT 2025
Thu Aug 21 14:35:21 EDT 2025
Thu Sep 04 19:50:13 EDT 2025
Wed Aug 13 04:04:15 EDT 2025
Mon Jul 21 06:05:18 EDT 2025
Thu Apr 24 23:07:17 EDT 2025
Tue Jul 01 04:08:53 EDT 2025
Fri Feb 21 02:40:11 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c540t-bdb5cafb20499942f9eba795035096ff66d3b9ac1d9598b637adc7501f0bbe213
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0001-5054-1727
0000-0003-3973-6501
0000-0002-6996-6431
0000-0001-7215-4410
0000-0002-5513-3324
0000-0002-5973-2092
0000-0002-2593-8631
0000-0001-7225-4403
0000-0002-3014-2603
0000-0001-9920-3075
0000-0002-3442-021X
0000-0001-7519-7029
OpenAccessLink https://www.proquest.com/docview/2382034106?pq-origsite=%requestingapplication%
PMID 32251294
PQID 2382034106
PQPubID 546298
PageCount 14
ParticipantIDs doaj_primary_oai_doaj_org_article_6f55e007701f4013b3a7b971436b8888
pubmedcentral_primary_oai_pubmedcentral_nih_gov_7089967
proquest_miscellaneous_2387253581
proquest_journals_2382034106
pubmed_primary_32251294
crossref_citationtrail_10_1038_s41467_020_15271_3
crossref_primary_10_1038_s41467_020_15271_3
springer_journals_10_1038_s41467_020_15271_3
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2020-03-23
PublicationDateYYYYMMDD 2020-03-23
PublicationDate_xml – month: 03
  year: 2020
  text: 2020-03-23
  day: 23
PublicationDecade 2020
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle Nature communications
PublicationTitleAbbrev Nat Commun
PublicationTitleAlternate Nat Commun
PublicationYear 2020
Publisher Nature Publishing Group UK
Nature Publishing Group
Nature Portfolio
Publisher_xml – name: Nature Publishing Group UK
– name: Nature Publishing Group
– name: Nature Portfolio
References Guo (CR31) 2017; 144
Lefort (CR9) 2008; 26
Garitaonandia (CR34) 2015; 10
Watanabe (CR49) 2007; 25
Forsyth (CR35) 2006; 8
Bhutani (CR11) 2016; 7
Simon, Keith (CR39) 2008; 9
Cervantes, Stringer, Shao, Tischfield, Stambrook (CR33) 2002; 99
Frigola (CR23) 2017; 49
Gehring, Fischer, Lawrence, Huber (CR52) 2015; 31
Kucab (CR41) 2019; 177
Draper (CR6) 2004; 22
Nguyen (CR16) 2014; 20
D’Antonio (CR40) 2018; 24
Pastor (CR32) 2016; 18
Fynes (CR37) 2014; 23
Barta (CR19) 2010; 28
Krueger, Andrews (CR51) 2011; 27
Tate (CR53) 2019; 47
Baker (CR4) 2016; 7
Spits (CR10) 2008; 26
von Meyenn (CR50) 2016; 39
Baker (CR7) 2007; 25
Avery (CR15) 2013; 1
Rugg-Gunn, Ferguson-Smith, Pedersen (CR30) 2007; 16
Zou (CR42) 2018; 9
Alexandrov (CR25) 2013; 500
Garcia-Muse, Aguilera (CR27) 2016; 17
Milholland (CR17) 2017; 8
Petljak (CR26) 2019; 176
Barbaric (CR14) 2014; 3
Jacobs (CR36) 2016; 6
Mandai, Kurimoto, Takahashi (CR1) 2017; 377
Olariu (CR13) 2010; 4
CR18
Guo (CR48) 2016; 6
Andrews (CR5) 2017; 9
Allegrucci (CR44) 2007; 16
Desmarais (CR20) 2012; 30
Pleasance (CR22) 2010; 463
Enver (CR28) 2005; 14
Kim (CR45) 2007; 17
Nik-Zainal (CR24) 2012; 149
Narva (CR38) 2013; 8
Amps (CR2) 2011; 29
Baghbaderani (CR8) 2016; 12
Ficz (CR46) 2013; 13
Mekhoubad (CR29) 2012; 10
CR21
Yagi (CR47) 2017; 548
Park, Qian, Zhang (CR43) 2012; 13
Merkle (CR12) 2017; 545
Rouhani (CR3) 2016; 12
B Milholland (15271_CR17) 2017; 8
HT Nguyen (15271_CR16) 2014; 20
M D’Antonio (15271_CR40) 2018; 24
MC Simon (15271_CR39) 2008; 9
C Allegrucci (15271_CR44) 2007; 16
I Garitaonandia (15271_CR34) 2015; 10
DE Baker (15271_CR7) 2007; 25
FJ Rouhani (15271_CR3) 2016; 12
K Bhutani (15271_CR11) 2016; 7
FT Merkle (15271_CR12) 2017; 545
PJ Rugg-Gunn (15271_CR30) 2007; 16
V Olariu (15271_CR13) 2010; 4
S Nik-Zainal (15271_CR24) 2012; 149
LB Alexandrov (15271_CR25) 2013; 500
JS Gehring (15271_CR52) 2015; 31
JG Tate (15271_CR53) 2019; 47
KP Kim (15271_CR45) 2007; 17
PW Andrews (15271_CR5) 2017; 9
JS Draper (15271_CR6) 2004; 22
J Frigola (15271_CR23) 2017; 49
M Petljak (15271_CR26) 2019; 176
K Jacobs (15271_CR36) 2016; 6
RB Cervantes (15271_CR33) 2002; 99
T Enver (15271_CR28) 2005; 14
M Mandai (15271_CR1) 2017; 377
BA Baghbaderani (15271_CR8) 2016; 12
F Krueger (15271_CR51) 2011; 27
JE Kucab (15271_CR41) 2019; 177
NR Forsyth (15271_CR35) 2006; 8
E Narva (15271_CR38) 2013; 8
S Avery (15271_CR15) 2013; 1
15271_CR21
S Mekhoubad (15271_CR29) 2012; 10
X Zou (15271_CR42) 2018; 9
M Yagi (15271_CR47) 2017; 548
F von Meyenn (15271_CR50) 2016; 39
C Park (15271_CR43) 2012; 13
ED Pleasance (15271_CR22) 2010; 463
K Fynes (15271_CR37) 2014; 23
N Lefort (15271_CR9) 2008; 26
T Barta (15271_CR19) 2010; 28
K Amps (15271_CR2) 2011; 29
K Watanabe (15271_CR49) 2007; 25
G Guo (15271_CR31) 2017; 144
15271_CR18
WA Pastor (15271_CR32) 2016; 18
G Guo (15271_CR48) 2016; 6
T Garcia-Muse (15271_CR27) 2016; 17
C Spits (15271_CR10) 2008; 26
I Barbaric (15271_CR14) 2014; 3
JA Desmarais (15271_CR20) 2012; 30
G Ficz (15271_CR46) 2013; 13
D Baker (15271_CR4) 2016; 7
References_xml – volume: 13
  start-page: 351
  year: 2013
  end-page: 359
  ident: CR46
  article-title: FGF signaling inhibition in ESCs drives rapid genome-wide demethylation to the epigenetic ground state of pluripotency
  publication-title: Cell Stem Cell
  doi: 10.1016/j.stem.2013.06.004
– volume: 12
  start-page: e1005932
  year: 2016
  ident: CR3
  article-title: Mutational history of a human cell lineage from somatic to induced pluripotent stem cells
  publication-title: PLoS Genet.
  doi: 10.1371/journal.pgen.1005932
– volume: 1
  start-page: 379
  year: 2013
  end-page: 386
  ident: CR15
  article-title: BCL-XL mediates the strong selective advantage of a 20q11.21 amplification commonly found in human embryonic stem cell cultures
  publication-title: Stem Cell Rep.
  doi: 10.1016/j.stemcr.2013.10.005
– volume: 8
  year: 2017
  ident: CR17
  article-title: Differences between germline and somatic mutation rates in humans and mice
  publication-title: Nat. Commun.
  doi: 10.1038/ncomms15183
– volume: 177
  start-page: 821
  year: 2019
  end-page: 836 e816
  ident: CR41
  article-title: A compendium of mutational signatures of environmental agents
  publication-title: Cell
  doi: 10.1016/j.cell.2019.03.001
– volume: 8
  start-page: 16
  year: 2006
  end-page: 23
  ident: CR35
  article-title: Physiologic oxygen enhances human embryonic stem cell clonal recovery and reduces chromosomal abnormalities
  publication-title: Cloning Stem Cells
  doi: 10.1089/clo.2006.8.16
– volume: 149
  start-page: 979
  year: 2012
  end-page: 993
  ident: CR24
  article-title: Mutational processes molding the genomes of 21 breast cancers
  publication-title: Cell
  doi: 10.1016/j.cell.2012.04.024
– volume: 29
  start-page: 1132
  year: 2011
  end-page: 1144
  ident: CR2
  article-title: Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage
  publication-title: Nat. Biotechnol.
  doi: 10.1038/nbt.2051
– volume: 3
  start-page: 142
  year: 2014
  end-page: 155
  ident: CR14
  article-title: Time-lapse analysis of human embryonic stem cells reveals multiple bottlenecks restricting colony formation and their relief upon culture adaptation
  publication-title: Stem Cell Rep.
  doi: 10.1016/j.stemcr.2014.05.006
– volume: 23
  start-page: 1910
  year: 2014
  end-page: 1922
  ident: CR37
  article-title: The differential effects of 2% oxygen preconditioning on the subsequent differentiation of mouse and human pluripotent stem cells
  publication-title: Stem Cells Dev.
  doi: 10.1089/scd.2013.0504
– volume: 31
  start-page: 3673
  year: 2015
  end-page: 3675
  ident: CR52
  article-title: SomaticSignatures: inferring mutational signatures from single-nucleotide variants
  publication-title: Bioinformatics
– volume: 463
  start-page: 191
  year: 2010
  end-page: 196
  ident: CR22
  article-title: A comprehensive catalogue of somatic mutations from a human cancer genome
  publication-title: Nature
  doi: 10.1038/nature08658
– volume: 26
  start-page: 1361
  year: 2008
  end-page: 1363
  ident: CR10
  article-title: Recurrent chromosomal abnormalities in human embryonic stem cells
  publication-title: Nat. Biotechnol.
  doi: 10.1038/nbt.1510
– volume: 20
  start-page: 168
  year: 2014
  end-page: 177
  ident: CR16
  article-title: Gain of 20q11.21 in human embryonic stem cells improves cell survival by increased expression of Bcl-xL
  publication-title: Mol. Hum. Reprod.
  doi: 10.1093/molehr/gat077
– ident: CR21
– volume: 25
  start-page: 207
  year: 2007
  end-page: 215
  ident: CR7
  article-title: Adaptation to culture of human embryonic stem cells and oncogenesis in vivo
  publication-title: Nat. Biotechnol.
  doi: 10.1038/nbt1285
– volume: 4
  start-page: 50
  year: 2010
  end-page: 56
  ident: CR13
  article-title: Modeling the evolution of culture-adapted human embryonic stem cells
  publication-title: Stem Cell Res.
  doi: 10.1016/j.scr.2009.09.001
– volume: 8
  start-page: e78847
  year: 2013
  ident: CR38
  article-title: Continuous hypoxic culturing of human embryonic stem cells enhances SSEA-3 and MYC levels
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0078847
– volume: 548
  start-page: 224
  year: 2017
  end-page: 227
  ident: CR47
  article-title: Derivation of ground-state female ES cells maintaining gamete-derived DNA methylation
  publication-title: Nature
  doi: 10.1038/nature23286
– volume: 9
  start-page: 285
  year: 2008
  end-page: 296
  ident: CR39
  article-title: The role of oxygen availability in embryonic development and stem cell function
  publication-title: Nat. Rev. Mol. Cell Biol.
  doi: 10.1038/nrm2354
– volume: 7
  start-page: 998
  year: 2016
  end-page: 1012
  ident: CR4
  article-title: Detecting genetic mosaicism in cultures of human pluripotent stem cells
  publication-title: Stem Cell Rep.
  doi: 10.1016/j.stemcr.2016.10.003
– volume: 10
  start-page: 595
  year: 2012
  end-page: 609
  ident: CR29
  article-title: Erosion of dosage compensation impacts human iPSC disease modeling
  publication-title: Cell Stem Cell
  doi: 10.1016/j.stem.2012.02.014
– volume: 39
  start-page: 104
  year: 2016
  end-page: 115
  ident: CR50
  article-title: Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification
  publication-title: Dev. Cell
  doi: 10.1016/j.devcel.2016.09.015
– volume: 24
  start-page: 883
  year: 2018
  end-page: 894
  ident: CR40
  article-title: Insights into the mutational burden of human induced pluripotent stem cells from an integrative multi-omics approach
  publication-title: Cell Rep.
  doi: 10.1016/j.celrep.2018.06.091
– volume: 10
  start-page: e0118307
  year: 2015
  ident: CR34
  article-title: Increased risk of genetic and epigenetic instability in human embryonic stem cells associated with specific culture conditions
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0118307
– volume: 18
  start-page: 323
  year: 2016
  end-page: 329
  ident: CR32
  article-title: Naive human pluripotent cells feature a methylation landscape devoid of blastocyst or germline memory
  publication-title: Cell Stem Cell
  doi: 10.1016/j.stem.2016.01.019
– ident: CR18
– volume: 9
  year: 2018
  ident: CR42
  article-title: Validating the concept of mutational signatures with isogenic cell models
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-018-04052-8
– volume: 144
  start-page: 2748
  year: 2017
  end-page: 2763
  ident: CR31
  article-title: Epigenetic resetting of human pluripotency
  publication-title: Development
  doi: 10.1242/dev.146811
– volume: 30
  start-page: 1385
  year: 2012
  end-page: 1393
  ident: CR20
  article-title: Human embryonic stem cells fail to activate CHK1 and commit to apoptosis in response to DNA replication stress
  publication-title: Stem Cells
  doi: 10.1002/stem.1117
– volume: 16
  start-page: 1253
  year: 2007
  end-page: 1268
  ident: CR44
  article-title: Restriction landmark genome scanning identifies culture-induced DNA methylation instability in the human embryonic stem cell epigenome
  publication-title: Hum. Mol. Genet.
  doi: 10.1093/hmg/ddm074
– volume: 47
  start-page: D941
  year: 2019
  end-page: D947
  ident: CR53
  article-title: COSMIC: the catalogue of somatic mutations in cancer
  publication-title: Nucleic Acids Res.
  doi: 10.1093/nar/gky1015
– volume: 545
  start-page: 229
  year: 2017
  end-page: 233
  ident: CR12
  article-title: Human pluripotent stem cells recurrently acquire and expand dominant negative P53 mutations
  publication-title: Nature
  doi: 10.1038/nature22312
– volume: 99
  start-page: 3586
  year: 2002
  end-page: 3590
  ident: CR33
  article-title: Embryonic stem cells and somatic cells differ in mutation frequency and type
  publication-title: Proc. Natl Acad. Sci. USA
  doi: 10.1073/pnas.062527199
– volume: 17
  start-page: 553
  year: 2016
  end-page: 563
  ident: CR27
  article-title: Transcription-replication conflicts: how they occur and how they are resolved
  publication-title: Nat. Rev. Mol. Cell Biol.
  doi: 10.1038/nrm.2016.88
– volume: 28
  start-page: 1143
  year: 2010
  end-page: 1152
  ident: CR19
  article-title: Human embryonic stem cells are capable of executing G1/S checkpoint activation
  publication-title: Stem Cells
– volume: 14
  start-page: 3129
  year: 2005
  end-page: 3140
  ident: CR28
  article-title: Cellular differentiation hierarchies in normal and culture-adapted human embryonic stem cells
  publication-title: Hum. Mol. Genet
  doi: 10.1093/hmg/ddi345
– volume: 27
  start-page: 1571
  year: 2011
  end-page: 1572
  ident: CR51
  article-title: Bismark: a flexible aligner and methylation caller for Bisulfite-Seq applications
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/btr167
– volume: 16
  start-page: R243
  issue: Spec No. 2
  year: 2007
  end-page: R251
  ident: CR30
  article-title: Status of genomic imprinting in human embryonic stem cells as revealed by a large cohort of independently derived and maintained lines
  publication-title: Hum. Mol. Genet.
  doi: 10.1093/hmg/ddm245
– volume: 6
  start-page: 330
  year: 2016
  end-page: 341
  ident: CR36
  article-title: Higher-density culture in human embryonic stem cells results in DNA damage and genome instability
  publication-title: Stem Cell Rep.
  doi: 10.1016/j.stemcr.2016.01.015
– volume: 9
  start-page: 1
  year: 2017
  end-page: 4
  ident: CR5
  article-title: Assessing the safety of human pluripotent stem cells and their derivatives for clinical applications
  publication-title: Stem Cell Rep.
  doi: 10.1016/j.stemcr.2017.05.029
– volume: 49
  start-page: 1684
  year: 2017
  end-page: 1692
  ident: CR23
  article-title: Reduced mutation rate in exons due to differential mismatch repair
  publication-title: Nat. Genet.
  doi: 10.1038/ng.3991
– volume: 6
  start-page: 437
  year: 2016
  end-page: 446
  ident: CR48
  article-title: Naive pluripotent stem cells derived directly from isolated cells of the human inner cell mass
  publication-title: Stem Cell Rep.
  doi: 10.1016/j.stemcr.2016.02.005
– volume: 12
  start-page: 394
  year: 2016
  end-page: 420
  ident: CR8
  article-title: Detailed characterization of human induced pluripotent stem cells manufactured for therapeutic applications
  publication-title: Stem Cell Rev.
  doi: 10.1007/s12015-016-9662-8
– volume: 26
  start-page: 1364
  year: 2008
  end-page: 1366
  ident: CR9
  article-title: Human embryonic stem cells reveal recurrent genomic instability at 20q11.21
  publication-title: Nat. Biotechnol.
  doi: 10.1038/nbt.1509
– volume: 17
  start-page: 1731
  year: 2007
  end-page: 1742
  ident: CR45
  article-title: Gene-specific vulnerability to imprinting variability in human embryonic stem cell lines
  publication-title: Genome Res.
  doi: 10.1101/gr.6609207
– volume: 377
  start-page: 792
  year: 2017
  end-page: 793
  ident: CR1
  article-title: Autologous induced stem-cell-derived retinal cells for macular degeneration
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMc1706274
– volume: 13
  start-page: 1123
  year: 2012
  end-page: 1129
  ident: CR43
  article-title: Genomic evidence for elevated mutation rates in highly expressed genes
  publication-title: EMBO Rep.
  doi: 10.1038/embor.2012.165
– volume: 22
  start-page: 53
  year: 2004
  end-page: 54
  ident: CR6
  article-title: Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells
  publication-title: Nat. Biotechnol.
  doi: 10.1038/nbt922
– volume: 500
  start-page: 415
  year: 2013
  end-page: 421
  ident: CR25
  article-title: Signatures of mutational processes in human cancer
  publication-title: Nature
  doi: 10.1038/nature12477
– volume: 7
  year: 2016
  ident: CR11
  article-title: Whole-genome mutational burden analysis of three pluripotency induction methods
  publication-title: Nat. Commun.
  doi: 10.1038/ncomms10536
– volume: 176
  start-page: 1282
  year: 2019
  end-page: 1294 e1220
  ident: CR26
  article-title: Characterizing mutational signatures in human cancer cell lines reveals episodic APOBEC mutagenesis
  publication-title: Cell
  doi: 10.1016/j.cell.2019.02.012
– volume: 25
  start-page: 681
  year: 2007
  end-page: 686
  ident: CR49
  article-title: A ROCK inhibitor permits survival of dissociated human embryonic stem cells
  publication-title: Nat. Biotechnol.
  doi: 10.1038/nbt1310
– volume: 99
  start-page: 3586
  year: 2002
  ident: 15271_CR33
  publication-title: Proc. Natl Acad. Sci. USA
  doi: 10.1073/pnas.062527199
– volume: 9
  start-page: 1
  year: 2017
  ident: 15271_CR5
  publication-title: Stem Cell Rep.
  doi: 10.1016/j.stemcr.2017.05.029
– volume: 16
  start-page: R243
  issue: Spec No. 2
  year: 2007
  ident: 15271_CR30
  publication-title: Hum. Mol. Genet.
  doi: 10.1093/hmg/ddm245
– volume: 3
  start-page: 142
  year: 2014
  ident: 15271_CR14
  publication-title: Stem Cell Rep.
  doi: 10.1016/j.stemcr.2014.05.006
– volume: 177
  start-page: 821
  year: 2019
  ident: 15271_CR41
  publication-title: Cell
  doi: 10.1016/j.cell.2019.03.001
– volume: 17
  start-page: 1731
  year: 2007
  ident: 15271_CR45
  publication-title: Genome Res.
  doi: 10.1101/gr.6609207
– volume: 10
  start-page: e0118307
  year: 2015
  ident: 15271_CR34
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0118307
– volume: 26
  start-page: 1364
  year: 2008
  ident: 15271_CR9
  publication-title: Nat. Biotechnol.
  doi: 10.1038/nbt.1509
– volume: 29
  start-page: 1132
  year: 2011
  ident: 15271_CR2
  publication-title: Nat. Biotechnol.
  doi: 10.1038/nbt.2051
– volume: 20
  start-page: 168
  year: 2014
  ident: 15271_CR16
  publication-title: Mol. Hum. Reprod.
  doi: 10.1093/molehr/gat077
– volume: 8
  start-page: 16
  year: 2006
  ident: 15271_CR35
  publication-title: Cloning Stem Cells
  doi: 10.1089/clo.2006.8.16
– volume: 8
  start-page: e78847
  year: 2013
  ident: 15271_CR38
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0078847
– volume: 7
  year: 2016
  ident: 15271_CR11
  publication-title: Nat. Commun.
  doi: 10.1038/ncomms10536
– volume: 8
  year: 2017
  ident: 15271_CR17
  publication-title: Nat. Commun.
  doi: 10.1038/ncomms15183
– volume: 23
  start-page: 1910
  year: 2014
  ident: 15271_CR37
  publication-title: Stem Cells Dev.
  doi: 10.1089/scd.2013.0504
– volume: 12
  start-page: 394
  year: 2016
  ident: 15271_CR8
  publication-title: Stem Cell Rev.
  doi: 10.1007/s12015-016-9662-8
– volume: 31
  start-page: 3673
  year: 2015
  ident: 15271_CR52
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/btv408
– volume: 49
  start-page: 1684
  year: 2017
  ident: 15271_CR23
  publication-title: Nat. Genet.
  doi: 10.1038/ng.3991
– volume: 9
  year: 2018
  ident: 15271_CR42
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-018-04052-8
– volume: 24
  start-page: 883
  year: 2018
  ident: 15271_CR40
  publication-title: Cell Rep.
  doi: 10.1016/j.celrep.2018.06.091
– volume: 14
  start-page: 3129
  year: 2005
  ident: 15271_CR28
  publication-title: Hum. Mol. Genet
  doi: 10.1093/hmg/ddi345
– volume: 47
  start-page: D941
  year: 2019
  ident: 15271_CR53
  publication-title: Nucleic Acids Res.
  doi: 10.1093/nar/gky1015
– volume: 548
  start-page: 224
  year: 2017
  ident: 15271_CR47
  publication-title: Nature
  doi: 10.1038/nature23286
– ident: 15271_CR21
– volume: 18
  start-page: 323
  year: 2016
  ident: 15271_CR32
  publication-title: Cell Stem Cell
  doi: 10.1016/j.stem.2016.01.019
– volume: 16
  start-page: 1253
  year: 2007
  ident: 15271_CR44
  publication-title: Hum. Mol. Genet.
  doi: 10.1093/hmg/ddm074
– volume: 545
  start-page: 229
  year: 2017
  ident: 15271_CR12
  publication-title: Nature
  doi: 10.1038/nature22312
– volume: 30
  start-page: 1385
  year: 2012
  ident: 15271_CR20
  publication-title: Stem Cells
  doi: 10.1002/stem.1117
– volume: 500
  start-page: 415
  year: 2013
  ident: 15271_CR25
  publication-title: Nature
  doi: 10.1038/nature12477
– volume: 26
  start-page: 1361
  year: 2008
  ident: 15271_CR10
  publication-title: Nat. Biotechnol.
  doi: 10.1038/nbt.1510
– volume: 176
  start-page: 1282
  year: 2019
  ident: 15271_CR26
  publication-title: Cell
  doi: 10.1016/j.cell.2019.02.012
– volume: 149
  start-page: 979
  year: 2012
  ident: 15271_CR24
  publication-title: Cell
  doi: 10.1016/j.cell.2012.04.024
– volume: 22
  start-page: 53
  year: 2004
  ident: 15271_CR6
  publication-title: Nat. Biotechnol.
  doi: 10.1038/nbt922
– volume: 6
  start-page: 330
  year: 2016
  ident: 15271_CR36
  publication-title: Stem Cell Rep.
  doi: 10.1016/j.stemcr.2016.01.015
– volume: 9
  start-page: 285
  year: 2008
  ident: 15271_CR39
  publication-title: Nat. Rev. Mol. Cell Biol.
  doi: 10.1038/nrm2354
– volume: 27
  start-page: 1571
  year: 2011
  ident: 15271_CR51
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/btr167
– volume: 1
  start-page: 379
  year: 2013
  ident: 15271_CR15
  publication-title: Stem Cell Rep.
  doi: 10.1016/j.stemcr.2013.10.005
– ident: 15271_CR18
  doi: 10.1101/430165
– volume: 144
  start-page: 2748
  year: 2017
  ident: 15271_CR31
  publication-title: Development
  doi: 10.1242/dev.146811
– volume: 463
  start-page: 191
  year: 2010
  ident: 15271_CR22
  publication-title: Nature
  doi: 10.1038/nature08658
– volume: 25
  start-page: 681
  year: 2007
  ident: 15271_CR49
  publication-title: Nat. Biotechnol.
  doi: 10.1038/nbt1310
– volume: 10
  start-page: 595
  year: 2012
  ident: 15271_CR29
  publication-title: Cell Stem Cell
  doi: 10.1016/j.stem.2012.02.014
– volume: 17
  start-page: 553
  year: 2016
  ident: 15271_CR27
  publication-title: Nat. Rev. Mol. Cell Biol.
  doi: 10.1038/nrm.2016.88
– volume: 4
  start-page: 50
  year: 2010
  ident: 15271_CR13
  publication-title: Stem Cell Res.
  doi: 10.1016/j.scr.2009.09.001
– volume: 13
  start-page: 1123
  year: 2012
  ident: 15271_CR43
  publication-title: EMBO Rep.
  doi: 10.1038/embor.2012.165
– volume: 28
  start-page: 1143
  year: 2010
  ident: 15271_CR19
  publication-title: Stem Cells
  doi: 10.1002/stem.451
– volume: 377
  start-page: 792
  year: 2017
  ident: 15271_CR1
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMc1706274
– volume: 7
  start-page: 998
  year: 2016
  ident: 15271_CR4
  publication-title: Stem Cell Rep.
  doi: 10.1016/j.stemcr.2016.10.003
– volume: 12
  start-page: e1005932
  year: 2016
  ident: 15271_CR3
  publication-title: PLoS Genet.
  doi: 10.1371/journal.pgen.1005932
– volume: 13
  start-page: 351
  year: 2013
  ident: 15271_CR46
  publication-title: Cell Stem Cell
  doi: 10.1016/j.stem.2013.06.004
– volume: 25
  start-page: 207
  year: 2007
  ident: 15271_CR7
  publication-title: Nat. Biotechnol.
  doi: 10.1038/nbt1285
– volume: 39
  start-page: 104
  year: 2016
  ident: 15271_CR50
  publication-title: Dev. Cell
  doi: 10.1016/j.devcel.2016.09.015
– volume: 6
  start-page: 437
  year: 2016
  ident: 15271_CR48
  publication-title: Stem Cell Rep.
  doi: 10.1016/j.stemcr.2016.02.005
SSID ssj0000391844
Score 2.5894465
Snippet The occurrence of repetitive genomic changes that provide a selective growth advantage in pluripotent stem cells is of concern for their clinical application....
Mutations in human pluripotent stem cells (PSC) and whether any form during culture prior to use in a human clinical context are a concern. Here, the authors...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
springer
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1528
SubjectTerms 13/100
38/23
38/70
49/47
631/114/2403
631/208/176/1988
631/208/726/649
631/532/2064/2117
Cell culture
Cell Culture Techniques - methods
Cell Line
Cell lines
Chromatin
Chromosomes
Chromosomes, Human, X - genetics
Culture
Culture Media - pharmacology
Cyclic GMP
Deoxyribonucleic acid
DNA
DNA Methylation
DNA Mutational Analysis
DNA, Intergenic - genetics
Enzyme inhibitors
Epigenesis, Genetic
Humanities and Social Sciences
Humans
Kinases
multidisciplinary
Mutation
Mutation Rate
Mutation rates
Oxidative Stress - drug effects
Oxidative Stress - genetics
Oxygen
Oxygen - chemistry
Oxygen - pharmacology
Pluripotency
Pluripotent Stem Cells - physiology
Rho-associated kinase
Science
Science (multidisciplinary)
Sequence Analysis, RNA
Stem cells
Whole Genome Sequencing
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3Ni9UwEB9kQfAirp_VVSJ407JtkibNUcVlEfXkwt5C0ibrwtou7_Uh_vc7k7TPfX5ePLZNIMxMJr_pZH4D8EKFtkbHiMYrXFVK2fvSS6dLo6R3fcDnhgqFP35Sxyfy_Wlzeq3VF90Jy_TAWXCHKjZNINKZqo4UC3jhtDfUtVt5jN5SmS-eedeCqeSDhcHQRc5VMpVoD9cy-QSKlqiTa12KnZMoEfb_DmX-elnyp4xpOoiO7sDtGUGy13nl-3AjDHfhZu4p-f0enH0YvzHif1izMbKvm5xqZ-cDW4og2dkK5cNSdz52ebFBtzEicp4YcToz-pO_ZlRatmJL95SJZYKOwDB67vMlr_twcvTu89vjcu6mUHaIyqbSo9g7Fz1PQY7k0QTvtGkotWhUjEr1whvX1b1pTOuV0K7vEE_UsfI-8Fo8gL1hHMIjYNFhEKkNiqQ30lcRp_OuRezFeR21DgXUi2RtN1ONU8eLC5tS3qK1WRsWtWGTNqwo4OV2zmUm2vjr6DeksO1IIslOL9B07Gw69l-mU8DBom4779y1RQjDKzzaK1XA8-1n3HMkfjeEcZPGaN4Qc1wBD7N1bFdCDhIxlCxA79jNzlJ3vwznXxKvt6YUrNIFvFos7Mey_iyKx_9DFE_gFqetUYmSiwPYm1ab8BTR1uSfpY11BShQI4U
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwEB6VIiQuiDcpBRmJGwQSO7HjA0KAqCpEObFSb5ad2NtKS1Kyuyr998w4yaKFpXvLxpacedjfZDLfALyUvspxY0TjFTZLi6JxqSusSrUsnG08XpdUKHzyTR7Pii-n5ekeTO2ORgEud4Z21E9q1i_e_Pp59R4d_t1QMl69XRbR3SkQoiateSpuwE08mSRZ-ckI9-POLDQGNMVYO7N76tb5FGn8d2HPfz-h_CuPGo-no7twZ8SV7MNgCPdgz7f34dbQafLqAcy_dpeMWCGWrAvsx3pIwLPzlk2lkWzeo9RY7NnHLhZr3Ew6xNMrRkzPjN7vLxkVnPVs6qmyYgNth2cYUzfDp18PYXb0-fun43TssZDWiNVWqUNl1DY4HkOfggftnVW6pISjliFI2QinbZ03utSVk0LZpkaUkYfMOc9z8Qj22671T4AFi6Gl0iiSRhcuCzid1xUiMs7zoJRPIJ8ka-qRgJz6YCxMTISLygzaMKgNE7VhRAKvNnMuBvqNa0d_JIVtRhJ1dvyj6-dm9EQjQ1l6YjHCZ6Dg0gmrnKY28NJV-EvgcFK3mczRILDhGR74mUzgxeY2eiKJ37a-W8cxipfEJ5fA48E6NiuhbRORVZGA2rKbraVu32nPzyLbt6LErFQJvJ4s7M-y_i-Kg-uf4inc5mT0mUi5OIT9Vb_2zxBdrdzz6DK_AZakH-E
  priority: 102
  providerName: Scholars Portal
– databaseName: Springer Nature OA Free Journals
  dbid: C6C
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3di9QwEB_OE8EX8dvqKRF802KbpEnzqIvHIeqTB_cWkjZZD-7aY7eL-N87k37I6in4uG0C2flIftPJ_AbglQp1iRsjGq9wRS5l63Mvnc6Nkt61AX9XVCj8-Ys6OZUfz6qzA-BzLUy6tJ8oLdM2Pd8Oe7uVyaUp2KFGrGUubsBNom4nvvyVWi3fVYjxvJZyqo8pRH3N1L0zKFH1X4cv_7wm-VuuNB1Bx3fhzoQd2btxtffgIHT34dbYTfLHA1h_6r8zYn7Ysj6yy92YZGfnHZvLH9l6g5JhqS8fu7rY4YbRI2YeGLE5M_qGv2VUVLZhc9-UgY3UHIFh3NyO17sewunxh6-rk3zqo5A3iMeG3KPAGxc9T-GN5NEE77SpKKloVIxKtcIb15StqUztldCubRBJlLHwPvBSPILDru_CE2DRYfioDYqkNdIXEafzpkbUxXkZtQ4ZlLNkbTORjFOviwubkt2itqM2LGrDJm1YkcHrZc7VSLHxz9HvSWHLSKLHTg_6zdpO5mJVrKpATEX4HyiA9MJpb6jVu_IY8tcZHM3qtpPPbi2CF17goV6oDF4ur9HbSPyuC_0ujdG8Is64DB6P1rGshLZGRE8yA71nN3tL3X_TnX9LjN6akq9KZ_BmtrBfy_q7KJ7-3_BncJuTExQi5-IIDofNLjxHRDX4F8mFfgLBqRp6
  priority: 102
  providerName: Springer Nature
Title Low rates of mutation in clinical grade human pluripotent stem cells under different culture conditions
URI https://link.springer.com/article/10.1038/s41467-020-15271-3
https://www.ncbi.nlm.nih.gov/pubmed/32251294
https://www.proquest.com/docview/2382034106
https://www.proquest.com/docview/2387253581
https://pubmed.ncbi.nlm.nih.gov/PMC7089967
https://doaj.org/article/6f55e007701f4013b3a7b971436b8888
Volume 11
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3da9swED_WhMFexr7nrgsa7G0ztS1Zsp9GGpqVsJaxrZA3YdlyVujsNE4Y--93J3-U7KN-MNiWQbo7ne5D-h3AW2mTEBUjCi_PAl-IwvhGZMpPpTBZYfE5poPC5xfy7FIslvGyC7g13bbKXic6RV3UOcXIj3FpiQJUuYH8sL7xqWoUZVe7EhoHMEYVnMQjGJ-cXnz-MkRZCP88EaI7LRPw5LgRTjeQ10QVXUOf761IDrj_X9bm35sm_8icugVp_ggedpYkm7asfwz3bPUE7re1JX89hdWn-icjHIiG1SX7sWtT7uyqYv1hSLbaIJ2Yq9LH1tc7VB81WtBbRtjOjCL6DaMjZhvWV1HZshaowzL0oot2s9czuJyffpud-V1VBT9H62zrGyR_npUmcs6OiMrUmkylMaUYU1mWUhbcpFkeFmmcJkZylRU52hVhGRhjo5A_h1FVV_YlsDJDZ1KlSJIiFSYo8fcoT9AGi6KwVMp6EPaU1XkHOU6VL661S33zRLfc0MgN7bihuQfvhn_WLeDGna1PiGFDSwLLdi_qzUp3c0_LMo4t4RbhGMidNDxTJqXC79IkeHlw1LNbdzO40bfy5sGb4TPOPSJ_Vtl659qoKCYEOQ9etNIx9IQUJdpSwgO1Jzd7Xd3_Ul19d_jeilKxUnnwvpew2279nxSHd4_iFTyISOgD7kf8CEbbzc6-RntqayZwoJYK78n84wTG0-ni62LSTSR8O5OziYtU4P1cJL8BD5okEQ
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VIgQXxLMEChgJThA1sR07OSDEa9nSbU-t1JuJE2epVJJlN6uqf4rfyIyTbLU8euvesnESZ16eyXi-AXipXBqjYUThFXkUSlna0Mpch5mSNi8dHidUKLx_oMZH8utxcrwBv4ZaGNpWOdhEb6jLpqBv5Du4tPAITW6k3s1-htQ1irKrQwuNTiz23PkZhmyLt7ufkL-vOB99Pvw4DvuuAmGB3kkbWnx8kVeWe2df8ipzNtdZQim2TFWVUqWwWV7EZZZkqVVC52WB62pcRdY6Hgu87zW4LoXICKs_HX1ZfdMhtPVUyr42JxLpzkJ6S0QxGvWPjUOxtv75NgH_8m3_3qL5R57WL3-jO3C791vZ-07Q7sKGq-_Bja6T5fl9mE6aM0aoEwvWVOzHskvws5OaDaWXbDpHrjDfE5DNTpdorBr011tGSNKM8gcLRgVtczb0bGlZBwviGMbsZbe17AEcXQm1H8Jm3dTuEbAqx9BVZ0iSMpM2qvByXqTo8XEeV1q7AOKBsqboAc6pz8ap8Yl2kZqOGwa5YTw3jAjg9eqaWQfvcenoD8Sw1UiC5vZ_NPOp6TXdqCpJHKEk4TtQ8GpFrm1GbeaVTfEXwPbAbtPbi4W5kO4AXqxOo6YT-fPaNUs_RvOE8OoC2OqkYzUTMsvouckA9JrcrE11_Ux98t2jiWtK_CodwJtBwi6m9X9SPL78LZ7DzfHh_sRMdg_2nsAtTgoQiZCLbdhs50v3FD251j7z6sPg21Xr6293_Foe
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VrUBcEG8CBYwEJ4g2sR07OSBEaVctLVWFqNSbGyf2Uqkkyz5U9a_x65jJY6vl0Vv3thtn5cx7Mp5vAF4rl8ZoGFF4RR6FUpY2tDLXYaakzUuH3xNqFP5yoHaO5Ofj5HgNfvW9MHSssreJjaEu64LekQ_RtfAITW6khr47FnG4Nfow-RnSBCmqtPbjNFoR2XMX55i-zd7vbiGv33A-2v72aSfsJgyEBUYq89DiVorcW94E_pL7zNlcZwmV2zLlvVKlsFlexGWWZKlVQudlgT429pG1jscC__cGrGv0iukA1je3Dw6_Lt_wEPZ6KmXXqROJdDiTjV2ijI2mycahWPGGzdCAf0W6fx_Y_KNq2zjD0V2400Wx7GMrdvdgzVX34WY71_LiAYz363NGGBQzVnv2Y9GW-9lpxfpGTDaeIo9YMyGQTc4WaLpqjN7njHClGVUTZoza26asn-AyZy1IiGOYwZftQbOHcHQt9H4Eg6qu3BNgPsdEVmdIkjKTNvJ4Oy9SjP84j73WLoC4p6wpOrhzmrpxZpqyu0hNyw2D3DANN4wI4O3ynkkL9nHl6k1i2HIlAXU3P9TTsen03iifJI4wk_AZKJW1Itc2o6Hzyqb4CWCjZ7fprMfMXMp6AK-Wl1Hvifx55epFs0bzhNDrAnjcSsdyJ2SkMY6TAegVuVnZ6uqV6vR7gy2uqQysdADvegm73Nb_SfH06qd4CbdQV83-7sHeM7jNSf4jEXKxAYP5dOGeY1g3ty86_WFwct0q-xuRA1-5
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Low+rates+of+mutation+in+clinical+grade+human+pluripotent+stem+cells+under+different+culture+conditions&rft.jtitle=Nature+communications&rft.au=Thompson%2C+Oliver&rft.au=von+Meyenn+Ferdinand&rft.au=Hewitt%2C+Zoe&rft.au=Alexander%2C+John&rft.date=2020-03-23&rft.pub=Nature+Publishing+Group&rft.eissn=2041-1723&rft.volume=11&rft.issue=1&rft_id=info:doi/10.1038%2Fs41467-020-15271-3&rft.externalDBID=HAS_PDF_LINK
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2041-1723&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2041-1723&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2041-1723&client=summon